NEW YORK, Sept. 4, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds buyers of Enochian BioSciences, Inc. securities. NOV between January 17, 2018 and June 27, 2022, both dates inclusive, (the “Collection Period”), including common shares issued by Enochian in a private placement on or about February 16, 2018 September 26, 2022 deadline for the plaintiff.

SO WHAT: If you purchased Enochian BioSciences securities during the Class Period, you may be entitled to compensation without payment of expenses or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To participate in the Enochian BioSciences class action lawsuit, go to https://rosenlegal.com/submit-form/?case_id=6517 or call Phillip Kim, Esq. toll free at 866-767-3653 or by email [email protected] or [email protected] for information about the Class Action. A class action lawsuit has already been filed. If you want to appear as lead plaintiff, you must call the court by September 26, 2022 at the latest. A lead plaintiff is a representative party acting on behalf of other group members in conducting the litigation.

WHY ROSES LAW: We encourage investors to select qualified advisors with a track record in leadership positions. Frequently, companies that issue notices do not have comparable experience, resources, or meaningful recognition from peers. Many of these law firms do not actually conduct securities class actions, but are merely intermediaries who refer clients or work with law firms who actually hear the cases. Be wise in choosing a lawyer. The Rosen law firm represents investors worldwide and focuses its practice on securities class actions and shareholder derivatives litigation. Rosen Law Firm has achieved the largest-ever settlement of a securities class action lawsuit against a Chinese company. Rosen Law Firm was ranked #1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The office has been…